ChandlerBHunterJ. Ventilator-associated pneumonia: a concise review. J Intensive Care Soc2009;10: 29–33.
2.
MastertonRGallowayAFrenchG. Guidelines for the management of hospital-acquired pneumonia in the UK. J Antimicrob Chemo2008;62: 5–34.
3.
MuscedereJGDayAHeylandDK. Mortality, attributable mortality, and clinical events as end points for clinical trials of ventilator-associated pneumonia and hospital-acquired pneumonia?Clin Infect Dis2010; 51(Supplement 1): S120–S125.
4.
WaghHAcharyaD. Ventilator-associated pneumonia – an overview. Br J Med Practioners2009;2: 16–19.
DallasJKollefM. VAT vs VAP. Are we heading toward clarity or confusion?Chest2009;135: 252–55.
7.
National Institute for Health and Clinical Excellence. Technical patient safety solutions for prevention of ventilator-associated pneumonia in adults: guidance. NICE; London:2008. http://www.nice.org.uk/PSG002 Accessed November 2011.
8.
PetersenISAruASkødtV. Evaluation of pneumonia diagnosis in intensive care patients. Scand J infect Dis1999;31: 299–303.
9.
FagonJYChastreJHanceAJ. Evaluation of clinical judgement in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest1993;103: 547–53.
10.
PuginJAuckenthalerRMiliN. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic ‘blind’ bronchoalveolar lavage fluid. Am Rev Resp Dis1991;1121–29.
11.
HoranTAndrusMDudeckM. CDC/NHSN surveillance definition of health care-associated infection criteria for specific types of infections in the acute care setting. Am J Infect Control2008;36: 309–32.
12.
Hospitals in Europe Link for Infection Control through Surveillance. Surveillance of Nosocomial Infections in Intensive Care Units. http://helics.univ-lyon1.fr/helicshome.htm (accessed 7th March 2010).
13.
LacheradeJCJongheBDGuezennecP. Intermittent subglottic secretion drainage and ventilator-associated pneumonia: a multi-center trial. Am J Resp Crit Care Med2010;182: 910–17.